iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Blair William & Co. IL

Blair William & Co. IL decreased its position in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC - Free Report) by 6.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 604,737 shares of the company's stock after selling 39,704 shares during the quarter. Blair William & Co. IL owned 1.93% of iRhythm Technologies worth $54,529,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Homestead Advisers Corp raised its position in shares of iRhythm Technologies by 31.9% in the fourth quarter. Homestead Advisers Corp now owns 28,100 shares of the company's stock worth $2,534,000 after acquiring an additional 6,800 shares during the period. EFG Asset Management North America Corp. boosted its position in iRhythm Technologies by 113.6% during the fourth quarter. EFG Asset Management North America Corp. now owns 28,430 shares of the company's stock worth $2,565,000 after purchasing an additional 15,118 shares in the last quarter. Segall Bryant & Hamill LLC grew its holdings in iRhythm Technologies by 5.1% in the fourth quarter. Segall Bryant & Hamill LLC now owns 139,391 shares of the company's stock valued at $12,569,000 after purchasing an additional 6,789 shares during the period. Vanguard Group Inc. increased its position in shares of iRhythm Technologies by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 3,136,370 shares of the company's stock valued at $282,806,000 after buying an additional 18,442 shares in the last quarter. Finally, LPL Financial LLC acquired a new position in shares of iRhythm Technologies during the 4th quarter worth approximately $243,000.

Remove Ads

iRhythm Technologies Trading Up 1.1 %

Shares of NASDAQ IRTC traded up $1.11 during trading on Tuesday, hitting $105.79. 68,584 shares of the company were exchanged, compared to its average volume of 459,708. The company has a debt-to-equity ratio of 9.00, a quick ratio of 6.12 and a current ratio of 6.27. iRhythm Technologies, Inc. has a 12-month low of $55.92 and a 12-month high of $128.52. The company has a fifty day moving average price of $108.02 and a 200-day moving average price of $90.38. The firm has a market capitalization of $3.32 billion, a PE ratio of -29.10 and a beta of 1.36.

iRhythm Technologies (NASDAQ:IRTC - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.29) by $0.30. The firm had revenue of $164.33 million for the quarter, compared to analyst estimates of $158.30 million. iRhythm Technologies had a negative net margin of 19.14% and a negative return on equity of 118.83%. As a group, equities research analysts expect that iRhythm Technologies, Inc. will post -1.98 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Canaccord Genuity Group upped their price objective on shares of iRhythm Technologies from $125.00 to $152.00 and gave the stock a "buy" rating in a research report on Monday, December 9th. Wells Fargo & Company upped their price target on shares of iRhythm Technologies from $86.00 to $104.00 and gave the stock an "equal weight" rating in a research report on Friday, February 21st. StockNews.com upgraded iRhythm Technologies from a "sell" rating to a "hold" rating in a report on Monday, February 24th. The Goldman Sachs Group increased their target price on iRhythm Technologies from $91.00 to $124.00 and gave the company a "neutral" rating in a report on Monday, February 24th. Finally, Needham & Company LLC lifted their price target on iRhythm Technologies from $125.00 to $138.00 and gave the stock a "buy" rating in a research note on Friday, February 21st. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company's stock. According to MarketBeat.com, iRhythm Technologies has an average rating of "Moderate Buy" and an average price target of $119.73.

iRhythm Technologies Profile

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.